Our team develops bespoke NGS panels precisely engineered to target specific therapeutic pathways or lineage-relevant markers, ensuring that your data captures the exact transcriptomic variables critical to your research.
Creative Biolabs operates a specialized technical framework dedicated to the isolation and high-depth sequencing of RNA species sequestered within circulating extracellular particles. By providing a methodologically robust avenue for researchers to intercept dynamic alterations in gene expression, our platform facilitates a deeper interrogation of the transcriptome. Consequently, investigators may gain granular insights into cellular lineage plasticity, metastatic signaling cascades, and the induction of resistance mechanisms within experimental models. Such data potentially streamlines lead optimization, allowing for more rigorous and informed decisions throughout the drug discovery process.
Circulating tumor RNA (ctRNA) represents the active signaling state in oncology research. Recent literature confirms that while DNA provides a static map of mutations, ctRNA protected within extracellular particles reveals real-time survival mechanisms and resistance. Creative Biolabs leverages these biological insights to capture the dynamic transcriptomic shifts that drive spread and immune evasion, providing a comprehensive view of behavior that is essential for modern drug development and discovery.
Prospective collaborators are encouraged to evaluate the potential impact of our methodologies on their research objectives, request a consultation.
Fig.1 Circulating tumor nucleic acid release mechanisms. 1
Our team develops bespoke NGS panels precisely engineered to target specific therapeutic pathways or lineage-relevant markers, ensuring that your data captures the exact transcriptomic variables critical to your research.
We utilize proprietary stabilization protocols that safeguard transcriptomic integrity during transit, allowing for the reliable processing of samples shipped from global research sites without the risk of RNA degradation.
Our platform features high-throughput capability designed to isolate extracellular particles from thousands of samples simultaneously, maintaining high recovery yields and exceptional consistency across diverse research cohorts and volumes.
We implement a robust framework based on Quality-by-Design principles, utilizing advanced analytical techniques to monitor every step of the transcriptomic sequencing process and ensure the highest data reliability.
While others prioritize static genomic mutations, we isolate operational messages that dictate resistance, capturing the real-time adaptive behavior of aggressive oncology models.
Our platform is methodologically optimized for identifying non-epithelial signals, ensuring that aggressive signatures and cellular transitions do not go undetected during screening.
We offer unmatched stabilization for circulating transcripts, significantly reducing degradation risks and sampling errors typically associated with the isolation of rare biological signals.
By focusing on high-depth RNA sequencing, we provide researchers with more comprehensive datasets compared to traditional methods, facilitating the precise identification of resistance drivers.
Qualified organizations are invited to ascertain the strategic benefits of the Creative Biolabs platform. Get a quote today.
While DNA tracks genomic mutations from dead cells, ctRNA profiles active signaling from viable cells. This allows researchers to detect functional changes that DNA cannot capture.
Yes. By focusing on RNA encapsulated within protected particles and using our specialized stabilization, we protect the transcripts from degradation, ensuring high-quality libraries even from standard research samples.
To further accelerate your immunotherapy program, Creative Biolabs offers several complementary services often utilized alongside our Circulating Tumor RNA Isolation & Profiling:
We utilize integrated multi-omic platforms to systematically analyze metabolic alterations in oncology models, offering granular insights into nutrient flux and metabolic reprogramming critical for identifying novel therapeutic vulnerabilities.
Learn More →We offer advanced analytical services to characterize metabolic heterogeneities at the organelle level, providing high-resolution data on compartmentalized enzyme activities and metabolite distributions within complex oncology research models.
Learn More →Creative Biolabs provides the most advanced transcriptomic solutions to accelerate your research programs. From metastatic target discovery to real-time response monitoring in models, our service delivers the functional depth required for the next generation of drug discovery.
To obtain further information and to delineate specific project requirements, please contact us.
Reference